C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -34,099 | N/A | N/A | N/A |
| Depreciation Amortization | 1,929 | N/A | N/A | N/A |
| Accounts receivable | 81,815 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,231 | N/A | N/A | N/A |
| Other Working Capital | 84,982 | N/A | N/A | N/A |
| Other Operating Activity | -83,244 | 0 | 0 | 0 |
| Operating Cash Flow | $55,614 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -334 | N/A | N/A | N/A |
| PPE Investments | -1,286 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,620 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 274 | N/A | N/A | N/A |
| Common Stock Repurchased | -30 | N/A | N/A | N/A |
| Financing Cash Flow | $244 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 38,888 | N/A | N/A | N/A |
| End Cash Position | 93,126 | N/A | N/A | N/A |
| Net Cash Flow | $54,238 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 55,614 | N/A | N/A | N/A |
| Capital Expenditure | -1,349 | N/A | N/A | N/A |
| Free Cash Flow | 54,265 | 0 | 0 | 0 |